At the time of writing, Elanco Animal Health Inc [ELAN] stock is trading at $19.2, up 0.52%. An important factor to consider is whether the stock is rising or falling in short-term value. The ELAN shares have gain 3.62% over the last week, with a monthly amount glided 9.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on July 17, 2025, when Leerink Partners upgraded its rating to a Outperform but kept the price target unchanged to $18 for it. Previously, William Blair upgraded its rating to Outperform on June 26, 2025. On December 09, 2024, UBS initiated with a Buy rating and assigned a price target of $18 on the stock. Leerink Partners started tracking the stock assigning a Market Perform rating and suggested a price target of $14 on December 02, 2024. Morgan Stanley downgraded its rating to a Equal-Weight and reduced its price target to $15 on September 19, 2024. Stifel upgraded its rating to Buy for this stock on January 05, 2024, and upped its price target to $20. In a note dated December 19, 2023, Jefferies initiated a Buy rating and provided a target price of $17 on this stock.
For the past year, the stock price of Elanco Animal Health Inc fluctuated between $8.02 and $19.26. Currently, Wall Street analysts expect the stock to reach $20.75 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $19.2 at the most recent close of the market. An investor can expect a potential return of 8.07% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
According to Elanco Animal Health Inc [NYSE:ELAN], the company’s sales were 4.48B for trailing twelve months, which represents an 4.81% jump. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.62.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Elanco Animal Health Inc [NYSE:ELAN] has a current ratio of 2.60. On the other hand, the Quick Ratio is 1.40, and the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 2.13, the price to book ratio is 1.41 and price to earnings (TTM) ratio is 22.00.
Transactions by insiders
Recent insider trading involved Todd S and Jennifer G Young Li, Former CFO, that happened on Aug 11 ’25 when 49333.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 07 ’25 to buy 10000.0 shares. Meanwhile, Director Kurzius Lawrence Erik bought 10000.0 shares on Mar 11 ’25.
